Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2026-03-05 @ 8:46 PM
Study NCT ID:
NCT04240106
Status:
COMPLETED
Last Update Posted:
2024-02-16
First Post:
2020-01-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)
Sponsor:
MedSIR
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MedOPP190
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |